Keros Therapeutics Inc
KROS
Market Cap$570.71M
Close$
$13.90
2.8% downside
Current Fair Value
2.8% downsideOvervalued by 2.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $570.71 Million |
|---|---|
| Enterprise Value | $29.64 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5 |
| Beta | 1.39 |
| Outstanding Shares | 40,337,720 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.03 |
|---|---|
| PEG | -8.84 |
| Price to Sales | - |
| Price to Book Ratio | 1.02 |
| Enterprise Value to Revenue | 45.53 |
| Enterprise Value to EBIT | -0.15 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.64 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data